Media company had claimed intellectual property rights for goods including antiperspirants, tuxedos and biofuels
Researchers express satisfaction that their work has been cited by companies in patent applications
Lack of consultation has turned potential allies into adversaries, but technology and the creative industries can work together
Move escalates battle over intellectual property theft between Beijing and Seoul in critical semiconductor sector
SoftBank-backed company is battling the US semiconductor maker over royalty payments
Publishers accuse company of ‘freeriding’ on valuable news content
Who’s being ripped off by a fake designer baseball cap?
IP protections must match the pace of technological progress
Critics want changes to local laws that allow widespread use of copyrighted material to train artificial intelligence models
Western companies press smartphone maker over alleged patent infringements
Pfizer and BioNTech infringed pharmaceutical group’s mRNA patent, High Court in London rules
2024’s ranking of intellectual property law firms; the Unified Patent Court’s first year; gender and race-based gaps in patent applications; AI’s ‘double-edged sword’; EU plans for gene-edited crops patent ban and new Standard Essential Patent rules
Listings are based on recommendations made by clients and peers to FT research partner Statista
New technology is set to radically change role of specialist practitioners
While companies may agree on need for more transparency, questions are raised over draft law’s practicality
Critics of plan include green activists, farmers, biotech start-ups and multinationals
Disparities contribute to income inequalities and influence who receives funding for invention, researchers say
UPC network handled hundreds of cases in first year, for companies and investors seeking multi-jurisdictional rulings
EU court finds chain could not show genuine use of term for poultry products in clash with Irish rival
US motorcycle company claims that a ‘motorbike-inspired’ T-shirt sold by the UK retailer rips off its logo
Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivals
A planned public vote on joining an EU body focused on IP protection has been scrapped
Moderna alleges Pfizer and BioNTech infringed its patents in use of mRNA platform
Factory inspectors refuse to visit country over fears they could fall foul of tightened rules
Registering name of dead Colombian drug kingpin would flout ‘fundamental values and moral standards’
